Basic Information
FANHDI FOR INJECTION 250 iu/vial
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN11521P
May 17, 2001
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB02BD02
Company Information
GRIFOLS ASIA PACIFIC PTE. LTD.
GRIFOLS ASIA PACIFIC PTE. LTD.
Active Ingredients
ANTIHEMOPHILIC FACTOR VIII (HUMAN)
Strength: 250 iu/vial
Detailed Information
Contraindications
**Contraindications** Caution is advised in patients with known allergic reactions to constituents of the preparation.
Indication Information
**Therapeutic indications** Fanhdi® is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical haemophilia A.